NOXOPHARM LIMITED - Announcements

Market Cap $23.37M Add to my watchlist

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel... Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.More

Announcements

Filter Results

All Price Sensitive Only

NOX	Important Brain Cancer Findings for NOX66 Program	PRICE SENSITIVE	29/08/17	259.63KB	Share
NOX	Reinstatement to Official Quotation	PRICE SENSITIVE	24/08/17	214.85KB	Share
NOX	Noxopharm raises $5.5 million to advance clinical program	PRICE SENSITIVE	24/08/17	237.74KB	Share
NOX	Suspension from Official Quotation	PRICE SENSITIVE	23/08/17	453.48KB	Share
NOX	Trading Halt Request		21/08/17	235.09KB	Share
NOX	Trading Halt	PRICE SENSITIVE	21/08/17	247.98KB	Share
NOX	NOX Corporate Presentation ahead of Conference		08/08/17	3.36MB	Share
NOX	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/17	449.71KB	Share
NOX	NOX Research Report prepared by APP Securities		27/07/17	233.75KB	Share
NOX	CEO Interview with FNN - Singapore and HK Roadshow		25/07/17	233.97KB	Share
NOX	New Corporate Presentation		25/07/17	1.41MB	Share
NOX	Noxopharm provides update on NOX66 Clinical Trial Program	PRICE SENSITIVE	06/07/17	395.44KB	Share
NOX	Idronoxil data provides hope to treat secondary brain cancer	PRICE SENSITIVE	19/06/17	260.62KB	Share
NOX	NOX66 confirmed Non-Toxic. Trial Cleared for Full Enrolment	PRICE SENSITIVE	05/06/17	251.11KB	Share
NOX	New Corporate Presentation		30/05/17	383.44KB	Share
NOX	St Vincents Cancer Study to Commence-NOX66 and Radiotherapy	PRICE SENSITIVE	29/05/17	377.16KB	Share
NOX	NOX makes strategic commitment to treatment of rare cancers	PRICE SENSITIVE	24/05/17	268.97KB	Share
NOX	Noxopharm Mid Year Investor Briefings		18/05/17	247.77KB	Share
NOX	Market Guidance for Next Six Months	PRICE SENSITIVE	02/05/17	250.8KB	Share
NOX	Appendix 4C - quarterly	PRICE SENSITIVE	27/04/17	511.86KB	Share
NOX	FNN Interview with NOX CEO Explaining Idronoxil-C Discovery		10/04/17	235.1KB	Share
NOX	NOX Files Patent Application on 'Smart' Idronoxil	PRICE SENSITIVE	10/04/17	255.86KB	Share
NOX	Appendix 3B		03/04/17	504.09KB	Share
NOX	NOX and Monash Uni Collaboration Receives Federal Grant	PRICE SENSITIVE	27/03/17	254.08KB	Share
NOX	Noxopharm and UNSW combine on stroke project	PRICE SENSITIVE	16/03/17	340.09KB	Share
NOX	Gold Coast Qld Mid-Year Briefing Details		10/03/17	249.65KB	Share
NOX	Notification of Release of Restricted Securities Escrow		07/03/17	323.83KB	Share
NOX	NOX researching rare Abscopal Response	PRICE SENSITIVE	03/03/17	332.93KB	Share
NOX	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	24/02/17	291.46KB	Share
NOX	NOX Presentation and Interview ASX The CEO Sessions		24/02/17	234.91KB	Share
NOX	Updated Share Trading Policy		23/02/17	418.71KB	Share
NOX	ASX CEO Presentation Feb 2017		21/02/17	9.73MB	Share
NOX	Upcoming Events and Presentations		15/02/17	235.91KB	Share
NOX	Change of Principal Place of Business		03/02/17	232.37KB	Share
NOX	Brain Cancer Study Commences	PRICE SENSITIVE	01/02/17	240.08KB	Share
NOX	First NOX66 Clinical Trial to Commence	PRICE SENSITIVE	31/01/17	252.46KB	Share
NOX	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/17	434.87KB	Share
NOX	Appointment of New Company Secretary		16/01/17	233.84KB	Share
NOX	Appendix 3B		09/01/17	186.19KB	Share
NOX	Change in substantial holding		20/12/16	123.83KB	Share
NOX	Change of Director's Interest Notice - ID		20/12/16	165.18KB	Share
NOX	Change of Director's Interest Notice - GK		20/12/16	205.65KB	Share
NOX	Market Capitalisation - further update		20/12/16	180.98KB	Share
NOX	Appendix 3B		20/12/16	200.8KB	Share
NOX	Market Capitalisation Update		19/12/16	110.63KB	Share
NOX	Results of Meeting		23/11/16	691.59KB	Share
NOX	Breakthrough in Delivering Idronoxil into Brain	PRICE SENSITIVE	23/11/16	170.15KB	Share
NOX	Corporate Presentation Updated		22/11/16	12.91MB	Share
NOX	Corporate Presentation		22/11/16	14.22MB	Share
NOX	Corporate Presentation Providing Clinical Program Guidance		22/11/16	125.51KB	Share
NOX	Medical Advisors Appointed for Extensive Clinical Program		17/11/16	140.33KB	Share
NOX	Change in substantial holding DH		14/11/16	117.05KB	Share
NOX	Appendix 4C - quarterly-NOX.AX	PRICE SENSITIVE	31/10/16	151.7KB	Share
NOX	Initial Clinic Study Announced and Approved-NOX.AX	PRICE SENSITIVE	26/10/16	140.66KB	Share
NOX	Noxopharm 2016 AGM Sydney Briefing-NOX.AX		24/10/16	372.41KB	Share
NOX	Notice of 2016 AGM and 2016 Annual Report-NOX.AX		21/10/16	1.04MB	Share
NOX	Corporate Presentation-NOX.AX		20/10/16	14.96MB	Share
NOX	Annual Report to shareholders-NOX.AX		03/10/16	708.79KB	Share
NOX	Appendix 4G-NOX.AX		03/10/16	224.42KB	Share
NOX	Amendment to Preliminary Final Report-NOX.AX	PRICE SENSITIVE	30/09/16	80.06KB	Share
NOX	Corporate Presentation for Roadshow-NOX.AX		12/09/16	685.61KB	Share
NOX	Preliminary Final Report-NOX.AX	PRICE SENSITIVE	31/08/16	337.29KB	Share
NOX	Change in substantial holding-NOX.AX		28/08/16	29.9KB	Share
NOX	Change in substantial holding-NOX.AX		25/08/16	29.9KB	Share
NOX	Change in substantial holding DH-NOX.AX		22/08/16	58.04KB	Share
NOX	Noxopharm to Initiate Radiotherapy Clinical Studies-NOX.AX	PRICE SENSITIVE	22/08/16	282.91KB	Share
NOX	Change of Director's Interest Notice - GK-NOX.AX		19/08/16	107.52KB	Share
NOX	Becoming a substantial holder-NOX.AX		10/08/16	177.01KB	Share
NOX	Becoming a substantial holder-NOX.AX		10/08/16	171.46KB	Share
NOX	Becoming a substantial holder-NOX.AX		10/08/16	73.82KB	Share
NOX	Initial Director's Interest Notice - PM-NOX.AX		10/08/16	110.93KB	Share
NOX	Initial Director's Interest Notice - ID-NOX.AX		10/08/16	110.99KB	Share
NOX	Initial Director's Interest Notice - GK-NOX.AX		10/08/16	114KB	Share
NOX	Noxopharm Provides Update on Inaugural Clinical Study-NOX.AX	PRICE SENSITIVE	10/08/16	105.34KB	Share
NOX	Noxopharm Limited commences trading on ASX-NOX.AX		09/08/16	272.33KB	Share
NOX	Performance Share Terms-NOX.AX		08/08/16	192.14KB	Share
NOX	Option Terms-NOX.AX		08/08/16	77.21KB	Share
NOX	Restricted Securities and Capital Structure-NOX.AX		08/08/16	356.73KB	Share
NOX	Securities Trading Policy-NOX.AX		08/08/16	123.61KB	Share
NOX	Financial Accounts-NOX.AX		08/08/16	711.7KB	Share
NOX	Constitution-NOX.AX		08/08/16	595.94KB	Share
NOX	ASX Market Release - Admission to Official List-NOX.AX	PRICE SENSITIVE	08/08/16	246.85KB	Share
NOX	Appendix 1A & Information Form and Checklist-NOX.AX		08/08/16	802.34KB	Share
NOX	Top 20 Holders-NOX.AX		08/08/16	46.7KB	Share
NOX	Distribution Schedule-NOX.AX		08/08/16	11.02KB	Share
NOX	Company's Admission Disclosures-NOX.AX		08/08/16	238.98KB	Share
NOX	ASX Market Release - Pre-Quotation Disclosure-NOX.AX		08/08/16	275.99KB	Share
NOX	ASX Market Release - Admission to Official List-NOX.AX	PRICE SENSITIVE	08/08/16	246.85KB	Share
NOX	Prospectus-NOX.AX		08/08/16	1.22MB	Share
NOX	ASX Notice - Admission and Commencement of Quotation-NOX.AX		08/08/16	302.25KB	Share

NOX Important Brain Cancer Findings for NOX66 Program
29/08/17	PRICE SENSITIVE	259.63KB	Share
NOX Reinstatement to Official Quotation
24/08/17	PRICE SENSITIVE	214.85KB	Share
NOX Noxopharm raises $5.5 million to advance clinical program
24/08/17	PRICE SENSITIVE	237.74KB	Share
NOX Suspension from Official Quotation
23/08/17	PRICE SENSITIVE	453.48KB	Share
NOX Trading Halt Request
21/08/17		235.09KB	Share
NOX Trading Halt
21/08/17	PRICE SENSITIVE	247.98KB	Share
NOX NOX Corporate Presentation ahead of Conference
08/08/17		3.36MB	Share
NOX Appendix 4C - quarterly
31/07/17	PRICE SENSITIVE	449.71KB	Share
NOX NOX Research Report prepared by APP Securities
27/07/17		233.75KB	Share
NOX CEO Interview with FNN - Singapore and HK Roadshow
25/07/17		233.97KB	Share
NOX New Corporate Presentation
25/07/17		1.41MB	Share
NOX Noxopharm provides update on NOX66 Clinical Trial Program
06/07/17	PRICE SENSITIVE	395.44KB	Share
NOX Idronoxil data provides hope to treat secondary brain cancer
19/06/17	PRICE SENSITIVE	260.62KB	Share
NOX NOX66 confirmed Non-Toxic. Trial Cleared for Full Enrolment
05/06/17	PRICE SENSITIVE	251.11KB	Share
NOX New Corporate Presentation
30/05/17		383.44KB	Share
NOX St Vincents Cancer Study to Commence-NOX66 and Radiotherapy
29/05/17	PRICE SENSITIVE	377.16KB	Share
NOX NOX makes strategic commitment to treatment of rare cancers
24/05/17	PRICE SENSITIVE	268.97KB	Share
NOX Noxopharm Mid Year Investor Briefings
18/05/17		247.77KB	Share
NOX Market Guidance for Next Six Months
02/05/17	PRICE SENSITIVE	250.8KB	Share
NOX Appendix 4C - quarterly
27/04/17	PRICE SENSITIVE	511.86KB	Share
NOX FNN Interview with NOX CEO Explaining Idronoxil-C Discovery
10/04/17		235.1KB	Share
NOX NOX Files Patent Application on 'Smart' Idronoxil
10/04/17	PRICE SENSITIVE	255.86KB	Share
NOX Appendix 3B
03/04/17		504.09KB	Share
NOX NOX and Monash Uni Collaboration Receives Federal Grant
27/03/17	PRICE SENSITIVE	254.08KB	Share
NOX Noxopharm and UNSW combine on stroke project
16/03/17	PRICE SENSITIVE	340.09KB	Share
NOX Gold Coast Qld Mid-Year Briefing Details
10/03/17		249.65KB	Share
NOX Notification of Release of Restricted Securities Escrow
07/03/17		323.83KB	Share
NOX NOX researching rare Abscopal Response
03/03/17	PRICE SENSITIVE	332.93KB	Share
NOX Appendix 4D and Half Year Accounts
24/02/17	PRICE SENSITIVE	291.46KB	Share
NOX NOX Presentation and Interview ASX The CEO Sessions
24/02/17		234.91KB	Share
NOX Updated Share Trading Policy
23/02/17		418.71KB	Share
NOX ASX CEO Presentation Feb 2017
21/02/17		9.73MB	Share
NOX Upcoming Events and Presentations
15/02/17		235.91KB	Share
NOX Change of Principal Place of Business
03/02/17		232.37KB	Share
NOX Brain Cancer Study Commences
01/02/17	PRICE SENSITIVE	240.08KB	Share
NOX First NOX66 Clinical Trial to Commence
31/01/17	PRICE SENSITIVE	252.46KB	Share
NOX Appendix 4C - quarterly
30/01/17	PRICE SENSITIVE	434.87KB	Share
NOX Appointment of New Company Secretary
16/01/17		233.84KB	Share
NOX Appendix 3B
09/01/17		186.19KB	Share
NOX Change in substantial holding
20/12/16		123.83KB	Share
NOX Change of Director's Interest Notice - ID
20/12/16		165.18KB	Share
NOX Change of Director's Interest Notice - GK
20/12/16		205.65KB	Share
NOX Market Capitalisation - further update
20/12/16		180.98KB	Share
NOX Appendix 3B
20/12/16		200.8KB	Share
NOX Market Capitalisation Update
19/12/16		110.63KB	Share
NOX Results of Meeting
23/11/16		691.59KB	Share
NOX Breakthrough in Delivering Idronoxil into Brain
23/11/16	PRICE SENSITIVE	170.15KB	Share
NOX Corporate Presentation Updated
22/11/16		12.91MB	Share
NOX Corporate Presentation
22/11/16		14.22MB	Share
NOX Corporate Presentation Providing Clinical Program Guidance
22/11/16		125.51KB	Share
NOX Medical Advisors Appointed for Extensive Clinical Program
17/11/16		140.33KB	Share
NOX Change in substantial holding DH
14/11/16		117.05KB	Share
NOX Appendix 4C - quarterly-NOX.AX
31/10/16	PRICE SENSITIVE	151.7KB	Share
NOX Initial Clinic Study Announced and Approved-NOX.AX
26/10/16	PRICE SENSITIVE	140.66KB	Share
NOX Noxopharm 2016 AGM Sydney Briefing-NOX.AX
24/10/16		372.41KB	Share
NOX Notice of 2016 AGM and 2016 Annual Report-NOX.AX
21/10/16		1.04MB	Share
NOX Corporate Presentation-NOX.AX
20/10/16		14.96MB	Share
NOX Annual Report to shareholders-NOX.AX
03/10/16		708.79KB	Share
NOX Appendix 4G-NOX.AX
03/10/16		224.42KB	Share
NOX Amendment to Preliminary Final Report-NOX.AX
30/09/16	PRICE SENSITIVE	80.06KB	Share
NOX Corporate Presentation for Roadshow-NOX.AX
12/09/16		685.61KB	Share
NOX Preliminary Final Report-NOX.AX
31/08/16	PRICE SENSITIVE	337.29KB	Share
NOX Change in substantial holding-NOX.AX
28/08/16		29.9KB	Share
NOX Change in substantial holding-NOX.AX
25/08/16		29.9KB	Share
NOX Change in substantial holding DH-NOX.AX
22/08/16		58.04KB	Share
NOX Noxopharm to Initiate Radiotherapy Clinical Studies-NOX.AX
22/08/16	PRICE SENSITIVE	282.91KB	Share
NOX Change of Director's Interest Notice - GK-NOX.AX
19/08/16		107.52KB	Share
NOX Becoming a substantial holder-NOX.AX
10/08/16		177.01KB	Share
NOX Becoming a substantial holder-NOX.AX
10/08/16		171.46KB	Share
NOX Becoming a substantial holder-NOX.AX
10/08/16		73.82KB	Share
NOX Initial Director's Interest Notice - PM-NOX.AX
10/08/16		110.93KB	Share
NOX Initial Director's Interest Notice - ID-NOX.AX
10/08/16		110.99KB	Share
NOX Initial Director's Interest Notice - GK-NOX.AX
10/08/16		114KB	Share
NOX Noxopharm Provides Update on Inaugural Clinical Study-NOX.AX
10/08/16	PRICE SENSITIVE	105.34KB	Share
NOX Noxopharm Limited commences trading on ASX-NOX.AX
09/08/16		272.33KB	Share
NOX Performance Share Terms-NOX.AX
08/08/16		192.14KB	Share
NOX Option Terms-NOX.AX
08/08/16		77.21KB	Share
NOX Restricted Securities and Capital Structure-NOX.AX
08/08/16		356.73KB	Share
NOX Securities Trading Policy-NOX.AX
08/08/16		123.61KB	Share
NOX Financial Accounts-NOX.AX
08/08/16		711.7KB	Share
NOX Constitution-NOX.AX
08/08/16		595.94KB	Share
NOX ASX Market Release - Admission to Official List-NOX.AX
08/08/16	PRICE SENSITIVE	246.85KB	Share
NOX Appendix 1A & Information Form and Checklist-NOX.AX
08/08/16		802.34KB	Share
NOX Top 20 Holders-NOX.AX
08/08/16		46.7KB	Share
NOX Distribution Schedule-NOX.AX
08/08/16		11.02KB	Share
NOX Company's Admission Disclosures-NOX.AX
08/08/16		238.98KB	Share
NOX ASX Market Release - Pre-Quotation Disclosure-NOX.AX
08/08/16		275.99KB	Share
NOX ASX Market Release - Admission to Official List-NOX.AX
08/08/16	PRICE SENSITIVE	246.85KB	Share
NOX Prospectus-NOX.AX
08/08/16		1.22MB	Share
NOX ASX Notice - Admission and Commencement of Quotation-NOX.AX
08/08/16		302.25KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 8.0¢		Change 0.000(0.00%)		Mkt cap ! $23.37M

Open	High	Low	Value	Volume
8.2¢	8.2¢	8.0¢	$5.491K	68.10K

Buyers (Bids)

No.	Vol.	Price($)
2	147568	8.0¢

Sellers (Offers)

Price($)	Vol.	No.
8.2¢	30000	1

View Market Depth

No.	Vol.	Price($)
2	147568	0.080
1	14084	0.071
1	10000	0.069
1	150000	0.066
1	100000	0.064

Price($)	Vol.	No.
0.082	30000	1
0.090	21000	2
0.091	10989	1
0.092	5555	1
0.096	2500	1

Last trade - 14.31pm 05/06/2024 (20 minute delay)


Last 8.2¢		Change 0.000 ( 5.13 %)
Open	High	Low	Volume
8.2¢	8.2¢	8.2¢	30000
Last updated 11.56am 05/06/2024 ?

NOX (ASX) Chart

NOXOPHARM LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories